[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100423472":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":18,"responsibleParty":64,"collaborators":66,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":7,"maxAge":77,"enrollmentInfo":78,"targetDuration":81,"studyType":82,"phases":7,"briefSummary":83,"conditions":84,"keywords":7,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"French Africa Pediatric Oncology Group","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Ndella Ms DIOUF, MD","CONTACT","00(221)77 656 49 13.","ndella.diouf@gfaop.org",{"name":15,"role":11,"phone":16,"phoneExt":7,"email":17},"BRENDA Ms MALLON, MSc","0033142115411","brenda.mallon@gustaveroussy.fr",[19,34,49],{"facility":20,"status":21,"city":22,"state":7,"zip":7,"country":23,"countryCode":7,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"CHU de Treichville à ABIDJAN","RECRUITING","Abidjan","Côte d’Ivoire",{"type":25,"coordinates":26},"Point",[27,28],-4.00167,5.35444,{"lat":28,"lon":27},[31],{"name":32,"role":11,"phone":7,"phoneExt":7,"email":33},"LINE COUITCHERE, DOCTOR","line.couitchere@gfaop.org",{"facility":35,"status":21,"city":36,"state":7,"zip":7,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":43,"contacts":44},"CHU Donka 030 BP 554","Conakry","Guinea","GN",{"type":25,"coordinates":40},[41,42],-13.67729,9.53795,{"lat":42,"lon":41},[45],{"name":46,"role":11,"phone":47,"phoneExt":7,"email":48},"Dr Aïssata BARRY, DR","00(224)622300084","docteumama@gmail.com",{"facility":50,"status":21,"city":51,"state":7,"zip":52,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"Hôpital Aristide Le Dantec, Avenue Pasteur,","Dakar","BP 3001","Senegal","SN",{"type":25,"coordinates":56},[57,58],-17.44406,14.6937,{"lat":58,"lon":57},[61],{"name":62,"role":11,"phone":7,"phoneExt":7,"email":63},"NDELLA DIOUF, DOCTOR","ndella61@hotmail.com",{"type":65,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[67],{"name":68,"class":6},"Gustave Roussy, Cancer Campus, Grand Paris","100423472","recommendations-for-the-treatment-of-children-with-acute-lymphoblastic-leukemia-in-the-gfaop-100423472",false,"NCT04794296","Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP","LALGFA2019","Inclusion Criteria:\n\nChildren 0 to 18 ALL first diagnosis No prior chemotherapy Cytology FAB L1 or L2\n\n\\-\n\nExclusion Criteria:\n\nALL L3 (Burkitt) ALL previously treated with chemotherapy Trisomy 21","ALL","18 Years",{"count":79,"type":80},500,"ESTIMATED","10 Years","OBSERVATIONAL","The LALGFA2019 Recommendations redefine the standard risk criteria and propose to introduce anthracycline induction in so-called high-risk forms (LAL line T and LAL line B with leukocytosis greater than or equal to 50 G\u002FL or in children less than 1 year of age or more than 10 years of age) as well as Endoxan and Methotrexate in high dose consolidation.",[85],"Childhood ALL","2026-02-27",{"date":88,"type":89},"2026-03-02","ACTUAL",{"date":91,"type":89},"2021-11-15",{"date":93,"type":80},"2030-12-31",{"name":5,"class":6},3]